REPLY
- PMID: 33876833
- DOI: 10.1002/hep.31861
REPLY
Comment on
-
Hematological and Genetic Markers in the Rational Approach to Patients With HCV Sustained Virological Response With or Without Persisting Cryoglobulinemic Vasculitis.Hepatology. 2021 Sep;74(3):1164-1173. doi: 10.1002/hep.31804. Epub 2021 May 26. Hepatology. 2021. PMID: 33721342 Free PMC article.
-
Letter to the Editor: Recurrent Cryoglobulinemic Vasculitis in the Era of Direct-Acting Antivirals: A Story Beyond Sustained Virological Response 12.Hepatology. 2021 Nov;74(5):2909. doi: 10.1002/hep.31860. Epub 2021 Aug 30. Hepatology. 2021. PMID: 33884650 No abstract available.
References
-
- Zignego AL, Ramos-Casals M, Ferri C, Saadoun D, Arcaini L, Roccatello D, et al. International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statement. Autoimmun Rev 2017;16:523-541.
-
- Gragnani L, Cerretelli G, Lorini S, Steidl C, Giovannelli A, Monti M, et al. Interferon-free therapy in hepatitis C virus mixed cryoglobulinaemia: a prospective, controlled, clinical and quality of life analysis. Aliment Pharmacol Ther 2018;48:440-450.
-
- Gragnani L, Fognani E, Piluso A, Boldrini B, Urraro T, Fabbrizzi A, et al. Long-term effect of HCV eradication in patients with mixed cryoglobulinemia: a prospective, controlled, open-label, cohort study. Hepatology 2015;61:1145-1153.
-
- Visentini M, Del Padre M, Colantuono S, Yang B, Minafò YA, Antonini S, et al. Long-lasting persistence of large B-cell clones in hepatitis C virus-cured patients with complete response of mixed cryoglobulinaemia vasculitis. Liver Int 2019;39:628-632.
Publication types
LinkOut - more resources
Other Literature Sources